RecruitingNCT06709690

A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases

Sponsor

Ruijin Hospital

Enrollment

35 participants

Start Date

Oct 25, 2024

Study Type

OBSERVATIONAL

Conditions

To investigate the feasibility of deep learning-assisted rapid silent PET/MR in pediatric applications.

Max Age: 18 Years

Children who have clinical symptoms and are suspected of having malignant tumors after being evaluated by clinical pediatricians and require 18F-FDG PET/MR examination to further clarify their conditions.
Signed and dated informed consent form
Commit to complying with the research procedures and cooperate in the implementation of the entire research process.
No gender restriction, aged between 0 and 18 years old.

Patients with serious illnesses that researchers consider unsuitable for participation in this clinical study. Such as severe heart and lung failure, severe bone marrow suppression, severe liver and kidney dysfunction, etc.
Patients with severe claustrophobia，epileptic seizures, respiratory distress who cannot lie down, and patients with mental anomalies who are unable to cooperate.
Patients with metal implants such as pacemakers, artificial metal heart valves, and neurostimulators in their bodies.
Non-compliant person.

Interested in this trial?

Get notified about updates and connect with the research team.

China, Shanghai Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT06709690